Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris

Roderfeld M, Buttner FH, Bartnik E, Tschesche H (2000)
PROTEIN EXPRESSION AND PURIFICATION 19(3): 369-374.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Roderfeld, M; Buttner, FH; Bartnik, E; Tschesche, HaraldUniBi
Einrichtung
Fakultät für Chemie > Biochemie I
Abstract / Bemerkung
A soluble, C-terminal truncated form of human membrane type 1 matrix metalloproteinase (MT1-MMP) containing the hemopexin-like domain was expressed in Pichia pastoris strain KM71. High levels of secreted protein were detected. Although the c-DNA for the proenzyme (Ala(21)-Glu(523) called Delta TM-MT1-MMP) was cloned, almost only active MT1-MMP (Tyr(112)-GlU(523)) with identical N-terminus as described for the wildtype enzyme was isolated. This active enzyme was highly purified and characterized with respect to its biochemical properties, The recombinant protein showed high stability against autolysis and proteolysis by yeast proteases, although the calculated in vivo half-life is rather low. The biochemical properties of this new MT1-MMP species were compared with the well-characterized catalytic domain (Ile(114)-Ile(318)) of MT1-MMP, The novel form of MT1-MMP exhibited a higher stability against autolysis than the isolated catalytic domain (Ile(114)-Ile(318)). (C) 2000AcademicPress.
Erscheinungsjahr
2000
Zeitschriftentitel
PROTEIN EXPRESSION AND PURIFICATION
Band
19
Ausgabe
3
Seite(n)
369-374
ISSN
1046-5928
Page URI
https://pub.uni-bielefeld.de/record/1619190

Zitieren

Roderfeld M, Buttner FH, Bartnik E, Tschesche H. Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris. PROTEIN EXPRESSION AND PURIFICATION. 2000;19(3):369-374.
Roderfeld, M., Buttner, F. H., Bartnik, E., & Tschesche, H. (2000). Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris. PROTEIN EXPRESSION AND PURIFICATION, 19(3), 369-374. https://doi.org/10.1006/prep.2000.1259
Roderfeld, M, Buttner, FH, Bartnik, E, and Tschesche, Harald. 2000. “Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris”. PROTEIN EXPRESSION AND PURIFICATION 19 (3): 369-374.
Roderfeld, M., Buttner, F. H., Bartnik, E., and Tschesche, H. (2000). Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris. PROTEIN EXPRESSION AND PURIFICATION 19, 369-374.
Roderfeld, M., et al., 2000. Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris. PROTEIN EXPRESSION AND PURIFICATION, 19(3), p 369-374.
M. Roderfeld, et al., “Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris”, PROTEIN EXPRESSION AND PURIFICATION, vol. 19, 2000, pp. 369-374.
Roderfeld, M., Buttner, F.H., Bartnik, E., Tschesche, H.: Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris. PROTEIN EXPRESSION AND PURIFICATION. 19, 369-374 (2000).
Roderfeld, M, Buttner, FH, Bartnik, E, and Tschesche, Harald. “Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris”. PROTEIN EXPRESSION AND PURIFICATION 19.3 (2000): 369-374.

4 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Functional characterization of Anopheles matrix metalloprotease 1 reveals its agonistic role during sporogonic development of malaria parasites.
Goulielmaki E, Sidén-Kiamos I, Loukeris TG., Infect Immun 82(11), 2014
PMID: 25183733
Latent MMP-9 is bound to TIMP-1 before secretion.
Roderfeld M, Graf J, Giese B, Salguero-Palacios R, Tschuschner A, Müller-Newen G, Roeb E., Biol Chem 388(11), 2007
PMID: 17976016
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
Hurst DR, Schwartz MA, Ghaffari MA, Jin Y, Tschesche H, Fields GB, Sang QX., Biochem J 377(pt 3), 2004
PMID: 14533979
Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris.
Stratmann B, Farr M, Tschesche H., Biol Chem 382(6), 2001
PMID: 11501766

40 References

Daten bereitgestellt von Europe PubMed Central.

Matrix metalloproteinases: a review.
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA., Crit. Rev. Oral Biol. Med. 4(2), 1993
PMID: 8435466
Tumor invasion and metastasis: an imbalance of positive and negative regulation
Liotta, Cancer Res. 51(), 1991
Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis
MacDougal, Cancer Metast. Rev. 14(), 1995
Changing views of the role of matrix metalloproteinases in metastasis.
Chambers AF, Matrisian LM., J. Natl. Cancer Inst. 89(17), 1997
PMID: 9293916
Structural properties of matrix metalloproteinases.
Bode W, Fernandez-Catalan C, Tschesche H, Grams F, Nagase H, Maskos K., Cell. Mol. Life Sci. 55(4), 1999
PMID: 10357232
Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'.
Bode W, Gomis-Ruth FX, Stockler W., FEBS Lett. 331(1-2), 1993
PMID: 8405391
A matrix metalloproteinase expressed on the surface of invasive tumour cells.
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M., Nature 370(6484), 1994
PMID: 8015608
Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K, Lohi J, Valtanen H, Keski-Oja J., Biochem. J. 334 ( Pt 2)(), 1998
PMID: 9716492
Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis.
Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, Seiki M., Int. J. Cancer 64(5), 1995
PMID: 7591310
Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y., Cancer Res. 57(10), 1997
PMID: 9158005
Expression of membrane-type matrix metalloproteinase in human gastric carcinomas.
Nomura H, Sato H, Seiki M, Mai M, Okada Y., Cancer Res. 55(15), 1995
PMID: 7614460
Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y., Cancer Res. 59(2), 1999
PMID: 9927064
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y., J. Biol. Chem. 272(4), 1997
PMID: 8999957
Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate.
Lohi J, Lehti K, Westermarck J, Kahari VM, Keski-Oja J., Eur. J. Biochem. 239(2), 1996
PMID: 8706726
Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y., Cancer Res. 56(12), 1996
PMID: 8665498
Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts
Li, Mol. Carcinogen. 22(), 1998
Shedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line.
Harayama T, Ohuchi E, Aoki T, Sato H, Seiki M, Okada Y., Jpn. J. Cancer Res. 90(9), 1999
PMID: 10551322
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor.
Lovejoy B, Cleasby A, Hassell AM, Longley K, Luther MA, Weigl D, McGeehan G, McElroy AB, Drewry D, Lambert MH., Science 263(5145), 1994
PMID: 8278810
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.
Bode W, Reinemer P, Huber R, Kleine T, Schnierer S, Tschesche H., EMBO J. 13(6), 1994
PMID: 8137810
NMR structure of inhibited catalytic domain of human stromelysin-1
Gooley, Nature Struct. Biol. 1(), 1994
Matrilysin-inhibitor complexes: common themes among metalloproteases.
Browner MF, Smith WW, Castelhano AL., Biochemistry 34(20), 1995
PMID: 7756291
X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily.
Dhanaraj V, Ye QZ, Johnson LL, Hupe DJ, Ortwine DF, Dunbar JB Jr, Rubin JR, Pavlovsky A, Humblet C, Blundell TL., Structure 4(4), 1996
PMID: 8740360
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-Ruth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W., Nature 389(6646), 1997
PMID: 9288970
X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
Grams F, Reinemer P, Powers JC, Kleine T, Pieper M, Tschesche H, Huber R, Bode W., Eur. J. Biochem. 228(3), 1995
PMID: 7737183
Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K., EMBO J. 17(17), 1998
PMID: 9724659
Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.
Prontera C, Mariani B, Rossi C, Poggi A, Rotilio D., Int. J. Cancer 81(5), 1999
PMID: 10328230
The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells.
Wylie S, MacDonald IC, Varghese HJ, Schmidt EE, Morris VL, Groom AC, Chambers AF., Clin. Exp. Metastasis 17(2), 1999
PMID: 10411102
Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.
Pei D, Weiss SJ., J. Biol. Chem. 271(15), 1996
PMID: 8621565
The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
Lichte A, Kolkenbrock H, Tschesche H., FEBS Lett. 397(2-3), 1996
PMID: 8955363
Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure
Gietz, Yeast 11(), 1996
Purification of human collagenases with a hydroxamic acid affinity column.
Moore WM, Spilburg CA., Biochemistry 25(18), 1986
PMID: 3021211
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Laemmli UK., Nature 227(5259), 1970
PMID: 5432063
Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels.
Heukeshoven J, Dernick R., Electrophoresis 9(1), 1988
PMID: 2466645
Microsequence analysis of peptides and proteins. VIII. Improved electroblotting of proteins onto membranes and derivatized glass-fiber sheets.
Xu QY, Shively JE., Anal. Biochem. 170(1), 1988
PMID: 2455458
A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.
Blake MS, Johnston KH, Russell-Jones GJ, Gotschlich EC., Anal. Biochem. 136(1), 1984
PMID: 6424501
Quantitative zymography: detection of picogram quantities of gelatinases.
Kleiner DE, Stetler-Stevenson WG., Anal. Biochem. 218(2), 1994
PMID: 8074288
Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.
Matsudaira P., J. Biol. Chem. 262(21), 1987
PMID: 3611052
A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Knight CG, Willenbrock F, Murphy G., FEBS Lett. 296(3), 1992
PMID: 1537400
Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2.
Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M., FEBS Lett. 393(1), 1996
PMID: 8804434
Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?
Murphy G, Knauper V., Matrix Biol. 15(8-9), 1997
PMID: 9138283
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 10910727
PubMed | Europe PMC

Suchen in

Google Scholar